Wenyu Wei1, Dongfang Li1, Xiangdong Cai1, Zhao Liu1, Zhongtian Bai2, Jianxi Xiao1. 1. State Key Laboratory of Applied Organic Chemistry, Key Laboratory of Nonferrous Metal Chemistry and Resources Utilization of Gansu Province, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, P. R. China. 2. The Second Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou 730000, Gansu Province, China.
Abstract
The construction of potent peptide probes for selectively detecting denatured collagen is crucial for a variety of widespread diseases. However, all of the denatured collagen-targeting peptide probes found till date primarily utilized the repetitive (Gly-X-Y) n sequences with exclusively imino acids Pro and Hyp in the X and Y positions, which stabilized the triple helical conformation of the peptide probes, resulting in severe obstacles for their clinical applications. A novel series of peptide probes have been constructed by incorporating nonimino acids at the X position of the (GPO)3GXO(GPO)4 sequence, while the X-site residue is varied as Tyr, Phe, Asp, and Ala, respectively. Peptide probes FAM-GYO and FAM-GFO containing aromatic residues Tyr and Phe at the X position showed similarly high binding affinity and tissue-staining efficacy as the well-established peptide probe FAM-GPO, while peptide probes FAM-GDO and FAM-GAO with the corresponding charged residue Asp and the hydrophobic residue Ala indicated much weaker binding affinity and tissue-staining capability. Furthermore, FAM-GYO and FAM-GFO could specifically detect denatured collagen in different types of mouse connective tissues and efficiently stain various human pathological tissues. We have revealed for the first time that the incorporation of nonimino acids, particularly aromatic residues at the X and Y positions of the repetitive (Gly-X-Y) n sequences, may provide a convenient strategy to create novel robust collagen-targeting peptide probes, which have promising diagnostic applications in collagen-involved diseases.
The construction of potent peptide probes for selectively detecting denatured collagen is crucial for a variety of widespread diseases. However, all of the denatured collagen-targeting peptide probes found till date primarily utilized the repetitive (Gly-X-Y) n sequences with exclusively imino acidsPro and Hyp in the X and Y positions, which stabilized the triple helical conformation of the peptide probes, resulting in severe obstacles for their clinical applications. A novel series of peptide probes have been constructed by incorporating nonimino acids at the X position of the (GPO)3GXO(GPO)4 sequence, while the X-site residue is varied as Tyr, Phe, Asp, and Ala, respectively. Peptide probes FAM-GYO and FAM-GFO containing aromatic residues Tyr and Phe at the X position showed similarly high binding affinity and tissue-staining efficacy as the well-established peptide probe FAM-GPO, while peptide probes FAM-GDO and FAM-GAO with the corresponding charged residue Asp and the hydrophobic residue Ala indicated much weaker binding affinity and tissue-staining capability. Furthermore, FAM-GYO and FAM-GFO could specifically detect denatured collagen in different types of mouse connective tissues and efficiently stain various human pathological tissues. We have revealed for the first time that the incorporation of nonimino acids, particularly aromatic residues at the X and Y positions of the repetitive (Gly-X-Y) n sequences, may provide a convenient strategy to create novel robust collagen-targeting peptide probes, which have promising diagnostic applications in collagen-involved diseases.
Collagen is a group of
extracellular matrix proteins with a unique triple helical structure.
As the principal component of an extracellular matrix, collagen is
ubiquitous in connective tissues such as skin, bone, tendon, and ligaments.[1−3] It provides a vital structural scaffold for tissue development and
mediates various cellular behaviors such as cell adhesion, proliferation,
migration, and differentiation.[4−6] Abnormal collagen remodeling has
been found to be intimately correlated with various critical diseases
such as cancer and fibrosis.[7−13] Collagen is widely considered as the key constituent of a tumor
microenvironment, and it can influence tumor cell behavior, increase
tumortissue stiffness, and regulate tumor immunity. Extensive clinical
data have identified collagen as a prognostic factor for cancer differentiation,
cancer invasion, lymph node metastasis, and the stage of cancer.[14,15] Imbalanced collagen synthesis and degradation have also been reported
as the leading causes of fibrosis in the lung and liver.[16,17]To decipher the pathogenesis and develop novel treatments
of these collagen-related diseases, extensive research has been conducted
to discover antibodies and peptide probes for detecting collagen.
An ELISA-based screening has discovered two monoclonal antibodies
E1E5 and E4A11 for specifically recognizing type II collagen.[18] Two peptides WREPSFCALS and LRELHLNNN derived
from the collagen-binding proteins have been identified to target
type I collagen.[19,20] A novel class of peptide probes
consisting of the repetitive (Gly-Pro-Hyp) sequences have recently been found to specifically recognize denatured
collagen.[21] However, their collagen-targeting
capability has been revealed to fully rely on the strict maintenance
of monomer conformation, and heating or UV pretreatments are required
to dissociate the peptide probes into the monomer state prior to the
assay.[22,23] Side-chain modifications of (Gly-Pro-Hyp) sequences have been introduced to weaken the
triple-helix stability as well as to maintain the specificity for
collagen detection.[24]The amino acid
content has been shown as a determinant factor in the triple helical
stability of collagen mimetic peptides. The close packing of the three
chains of collagen requires Gly to be every third residue, leading
to the characteristic (Gly-X-Y) amino
acid sequence pattern.[25−30] The Gly-Pro-Hyp triplet has been found to be the most stabilizing
sequence for the triple helical structure.[31,32] Studies on a series of host–guest peptides have indicated
that the identity of the residue in the X and Y positions of the (Gly-X-Y) sequence significantly influenced their triple
helical stability. It revealed that Pro and Arg were the most favored
residues in the X position to stabilize the triple helical structure,
while aromatic residues Y, F, and W were the most destabilizing residues
in the X position.[33−39]To discover novel collagen-targeting peptides with weaker
triple helical propensity, we have constructed a series of peptide
probes consisting of the (GPO)3GXO(GPO)4 sequences
(O, (2S,4R)-4-hydroxyproline), while
X represents different types of amino acids. We have systematically
investigated the effect of the identity of the X residue on the collagen-targeting
capability and have found two peptide probes FAM-GYO and FAM-GFO with
the aromatic residues Tyr and Phe in the X position displaying superior
binding affinity toward denatured collagen. It provided a new convenient
strategy to construct collagen-targeting peptides by incorporating
appropriate nonimino acids at the X and Y positions, which have promising
diagnostic applications in collagen-involved diseases.
Results and Discussion
Design of Fluorescent Collagen-Targeting
Peptide Probes
All of the reported peptide probes that could
specifically recognize denatured collagen are composed of the (Gly-X-Y) sequences, with the residues at the X and Y
positions as purely imino acids (Pro or Hyp). The inclusion of imino
acids at the X and Y positions is known to strongly stabilize the
triple helical structure, which could pose severe drawbacks of the
peptide probes to target denatured collagen, which required a single-stranded
conformation. Herein, we have constructed a novel series of peptide
probes by introducing nonimino acids at the X positions of the collagen-targeting
sequences (GPO)3GXO(GPO)4 (Table ). FAM (5(6)-carboxyfluorescein),
a widely used fluorescent dye, is conjugated with the N-terminal of
the peptide sequences. Peptide probe FAM-GPO containing Pro at the
X position is constructed as a control, which has been shown to bind
denatured collagen with high selectivity. Peptide probes containing
different types of imino acids (Tyr, Phe, Asp, and Ala) at the X position
are denoted as FAM-GYO, FAM-GFO, FAM-GDO, and FAM-GAO, respectively
(Table ). The substitution
of Pro by aromatic residues Tyr and Phe, the charged residue Asp,
and the hydrophobic residue Ala has been reported to weaken the triple
helical stability of collagen mimetic peptides in the context of (GPO)3GXO(GPO)4 by 13, 13.8, 7.2, and 5.6 °C, respectively.[34]
Table 1
Construction of Collagen-Targeting
Peptide Probesa
name
sequence
m/z calculated
m/z found
FAM-GPO
FAM-(GPO)3GPO(GPO)4
[M + Na]+
2536.6
2536.8
FAM-GYO
FAM-(GPO)3GYO(GPO)4
[M + Na]+
2602.7
2602.0
FAM-GFO
FAM-(GPO)3GFO(GPO)4
[M + Na]+
2586.7
2587.0
FAM-GDO
FAM-(GPO)3GDO(GPO)4
[M]+
2531.6
2531.3
FAM-GAO
FAM-(GPO)3GAO(GPO)4
[M]+
2487.6
2487.5
FAM-2GYO
FAM-(GPO)2GYOGPOGYO(GPO)3
[M + Na]+
2668.7
2668.2
FAM-2GAO
FAM-(GPO)2GAOGPOGAO(GPO)3
[M + Na]+
2484.5
2484.8
FAM-Control
FAM-PPPGGGOOOPGOOPPGGGOOOPPG
[M + Na]+
2536.6
2536.9
Sequences and Mass Characterization of the Peptide Probes. FAM, 5(6)-carboxyfluorescein;
O, (2S,4R)-4-hydroxyproline.
Sequences and Mass Characterization of the Peptide Probes. FAM, 5(6)-carboxyfluorescein;
O, (2S,4R)-4-hydroxyproline.Furthermore, peptide probes FAM-2GYO
and FAM-2GAO are designed to contain Tyr and Ala at two X positions
of the FAM-(GPO)2GXOGPOGXO(GPO)3 sequences,
respectively, to evaluate if the introduction of multiple nonimino
acids affects the collagen-binding affinity (Table ). Peptide probe FAM-control consisting of
a random G8P8O8 sequence is synthesized
as a negative control. We hypothesize that the replacement of Pro
by other types of amino acids at one or two X positions of these peptide
probes may modulate their collagen-targeting capability differently.
Collagen-Targeting Capability of the Fluorescent
Peptide Probes
The collagen-targeting capability of the peptide
probes FAM-GPO, FAM-GYO, FAM-GFO, FAM-GDO, FAM-GAO, FAM-2GYO, FAM-2GAO,
and FAM-control was evaluated by the binding experiments (Figure a). As expected,
peptide probe FAM-GPO showed high binding affinity toward gelatin,
while the negative control probe FAM-control showed little binding.
Notably, FAM-GYO and FAM-GFO showed similarly high fluorescence intensity
as FAM-GPO, suggesting that the inclusion of aromatic residues Tyr
and Phe at the X position did not alter their collagen-binding affinity
(Figure a). However,
FAM-GDO and FAM-GAO showed much weaker fluorescence intensity, indicating
that the presence of charged residue Asp and hydrophobic residue Ala
significantly reduced their collagen-binding ability. Furthermore,
the introduction of Tyr or Ala at two X positions led to much weaker
binding affinity than that at only one X position, suggesting that
two or more substitutions of Pro by other types of residues in the
(Gly-Pro-Hyp)8 sequence may significantly interfere in
the collagen-binding capability. Peptide probes FAM-GYO and FAM-2GYO
both displayed much higher binding affinity than their counterparts
FAM-GAO and FAM-2GAO, indicating that Tyr is a more favorable residue
at the X position than Ala in terms of collagen-binding ability (Figure a).
Figure 1
Binding specificity of
the peptide probes. (a) Binding affinity of peptide probes FAM-GPO,
FAM-GYO, FAM-GFO, FAM-GDO, FAM-GAO, FAM-2GYO, FAM-2GAO, and FAM-control
toward gelatin films in a 96-well plate. (b) Binding affinity of FAM-GPO,
FAM-GYO, and FAM-GFO with denatured type I collagen (gray), pepsin
(red), trypsin (green), and hemoglobin (blue), respectively. The peptide
probes were incubated in the wells coated with these proteins. The
fluorescence intensity was measured at an excitation wavelength of
495 nm and at an emission wavelength of 541 nm.
Binding specificity of
the peptide probes. (a) Binding affinity of peptide probes FAM-GPO,
FAM-GYO, FAM-GFO, FAM-GDO, FAM-GAO, FAM-2GYO, FAM-2GAO, and FAM-control
toward gelatin films in a 96-well plate. (b) Binding affinity of FAM-GPO,
FAM-GYO, and FAM-GFO with denatured type I collagen (gray), pepsin
(red), trypsin (green), and hemoglobin (blue), respectively. The peptide
probes were incubated in the wells coated with these proteins. The
fluorescence intensity was measured at an excitation wavelength of
495 nm and at an emission wavelength of 541 nm.Since peptide probes FAM-GYO and FAM-GFO showed similarly strong
binding affinity as FAM-GPO, their specificity to recognize denatured
collagen was further examined (Figure b). Wells of a 96-well plate were coated with denatured
type I collagen, pepsin, trypsin, and hemoglobin, respectively. Similarly
as FAM-GPO, FAM-GYO and FAM-GFO showed little binding with all other
proteins besides denatured type I collagen (Figure b). It demonstrated that peptide probes FAM-GYO
and FAM-GFO could detect denatured collagen with high specificity.
Tissue Staining by Fluorescent Peptide Probes
The tissue-staining capabilities of peptide probes FAM-GPO, FAM-GYO,
FAM-GFO, FAM-GDO, FAM-GAO, FAM-2GYO, FAM-2GAO, and FAM-control were
evaluated (Figure ). Fluorescence micrographs of impaired mouse ear tissues stained
with FAM-GPO showed a strong green fluorescence, confirming that FAM-GPO
selectively recognizes denatured collagen, which was consistent with
previous reports (Figure a). Fluorescence micrographs of impaired mouse ear tissues
stained with other peptide probes showed different levels of green
fluorescence, while FAM-GYO and FAM-GFO displayed the strongest fluorescence
and thus highest staining efficacy (Figure b,c). In contrast, FAM-GDO, FAM-GAO, and
FAM-2GYO showed weaker fluorescence and less staining efficacy, while
FAM-2GAO and FAM-control showed a little green fluorescence and complete
loss of the collagen-targeting capability (Figure d–h). These results demonstrated that
peptide probes FAM-GYO and FAM-GFO possessed similarly strong tissue-staining
capability as FAM-GPO.
Figure 2
Fluorescence micrographs of impaired mouse ear tissues
stained with FAM-GPO (a), FAM-GYO (b), FAM-GFO (c), FAM-GDO (d), FAM-GAO
(e), FAM-2GYO (f), FAM-2GAO (g), and FAM-control (h). The peptide
probes with a concentration of 15 μM were prepared in 10 mM
phosphate-buffered saline (PBS) buffer and preheated at 80 °C
to ensure monomer conformation. Scale bar = 50 μm.
Fluorescence micrographs of impaired mouse ear tissues
stained with FAM-GPO (a), FAM-GYO (b), FAM-GFO (c), FAM-GDO (d), FAM-GAO
(e), FAM-2GYO (f), FAM-2GAO (g), and FAM-control (h). The peptide
probes with a concentration of 15 μM were prepared in 10 mM
phosphate-buffered saline (PBS) buffer and preheated at 80 °C
to ensure monomer conformation. Scale bar = 50 μm.
Specific Recognition of Denatured Collagen
by Peptide Probes FAM-GYO and FAM-GFO
The collagen-targeting
features of the two most promising peptide probes FAM-GYO and FAM-GFO
were further examined (Figure ). Normal and impaired mouse intestine tissue sections were
stained with FAM-GPO, FAM-GYO, and FAM-GFO. Fluorescence micrographs
of the stained normal intestine sections all showed a little green
fluorescence, indicating the inability of the three peptide probes
to target intact collagen (Figure a,d,g). In contrast, the fluorescence micrographs of
the stained impaired intestine sections all showed a significant green
fluorescence, demonstrating the high specificity of the three peptide
probes to recognize denatured collagen (Figure b,e,h). The costaining of 4′,6-diamidino-2-phenylindole
(DAPI) for the cell nuclei (blue) confirmed the distinct collagen
distribution in intestine tissues (Figure ).
Figure 3
Specific recognition of denatured collagen by
peptide probes FAM-GYO and FAM-GFO. Fluorescence micrographs of normal
(a, d, g) and impaired (b, e, h) mouse intestine tissue sections stained
with FAM-GPO (a, b), FAM-GYO (d, e), and FAM-GFO (g, h). Fluorescence
micrographs of impaired mouse intestine tissue sections stained with
FAM-GPO (c), FAM-GYO (f), and FAM-GFO (i) in the presence of a peptide
inhibitor G(POG)10. The tissue sections were costained
by DAPI for cell nuclei (blue). Scale bar = 50 μm.
Specific recognition of denatured collagen by
peptide probes FAM-GYO and FAM-GFO. Fluorescence micrographs of normal
(a, d, g) and impaired (b, e, h) mouse intestine tissue sections stained
with FAM-GPO (a, b), FAM-GYO (d, e), and FAM-GFO (g, h). Fluorescence
micrographs of impaired mouse intestine tissue sections stained with
FAM-GPO (c), FAM-GYO (f), and FAM-GFO (i) in the presence of a peptide
inhibitor G(POG)10. The tissue sections were costained
by DAPI for cell nuclei (blue). Scale bar = 50 μm.Inhibition experiments were performed using peptide G(POG)10 as an inhibitor to evaluate the binding pattern of the three
peptide probes FAM-GPO, FAM-GYO, and FAM-GFO (Figure c,f,i). Peptide G(POG)10 was applied
onto the intestine tissues prior to the staining with the peptide
probes. In the presence of G(POG)10, the fluorescence micrographs
of the impaired intestine tissues all showed a weak fluorescence,
indicating that G(POG)10 efficiently blocked the staining
of denatured collagen by the peptide probes. Similarly as FAM-GPO,
peptide probes FAM-GYO and FAM-GFOprobably shared the same mechanism
by hybridizing with the unfolded sites and specifically binding to
denatured collagen.Peptide probes FAM-GYO and FAM-GFO were
further applied to stain impaired mouse heart, cornea, and cartilage
tissue sections (Figure ). Fluorescence micrographs of all of the stained tissues showed
a strong green fluorescence, demonstrating the robustness of both
peptide probes to target denatured collagen in a broad variety of
connective tissues. DAPI was applied to stain the nuclei (blue) and
colocalize collagen (Figure ).
Figure 4
Fluorescence micrographs of impaired mouse heart (a, d), cornea
(b, e), and cartilage (c, f) tissue sections stained with peptide
probes FAM-GYO (a–c) and FAM-GFO (d–f) (green). The
tissue sections were costained by DAPI for cell nuclei (blue). Scale
bar = 50 μm.
Fluorescence micrographs of impaired mouse heart (a, d), cornea
(b, e), and cartilage (c, f) tissue sections stained with peptide
probes FAM-GYO (a–c) and FAM-GFO (d–f) (green). The
tissue sections were costained by DAPI for cell nuclei (blue). Scale
bar = 50 μm.
Human
Pathological Tissue Staining by Peptide Probes FAM-GYO and FAM-GFO
The applicability of peptide probes FAM-GYO and FAM-GFO to specifically
target denatured collagen in human pathological tissues was further
examined (Figures and 6). Fluorescence micrographs of formalin-fixed
paraffin-embedded (FFPE) tissues of humanliver fibrosis, liver cancer,
rectal cancer, and esophageal cancer stained with FAM-GYO all showed
an intense green fluorescence, indicating that FAM-GYO could detect
degenerated collagen in various pathological tissues (Figure ). DAPI costaining of the nuclei
confirmed the unique collagen distribution in a diseased connective
tissue (Figure ).
The fluorescence micrographs of FFPE tissues of humanliver fibrosis,
liver cancer, rectal cancer, and esophageal cancer stained with FAM-GFO
and DAPI demonstrated that FAM-GFO could highly sensitively and selectively
target denatured collagen in different types of pathological connective
tissues (Figure ).
It suggested that the two novel peptide probes FAM-GYO and FAM-GFO
were similar broad-spectrum biosensors as FAM-GPO for detecting denatured
collagen.
Figure 5
Pathological human tissue staining using fluorescent peptide probe
FAM-GYO. Fluorescence micrographs of liver fibrosis (a, e, i), liver
cancer (b, f, j), rectal cancer (c, g, k), and esophageal cancer (d,
h, l); tissue sections stained with FAM-GYO (in green) and DAPI (in
blue). Scale bar = 50 μm.
Figure 6
Pathological
human tissue staining using fluorescent peptide probe FAM-GFO. Fluorescence
micrographs of liver fibrosis (a, e, i), liver cancer (b, f, j), rectal
cancer (c, g, k), and esophageal cancer (d, h, l); tissue sections
stained with FAM-GFO (in green) and DAPI (in blue). Scale bar = 50
μm.
Pathological humantissue staining using fluorescent peptide probe
FAM-GYO. Fluorescence micrographs of liver fibrosis (a, e, i), liver
cancer (b, f, j), rectal cancer (c, g, k), and esophageal cancer (d,
h, l); tissue sections stained with FAM-GYO (in green) and DAPI (in
blue). Scale bar = 50 μm.Pathological
humantissue staining using fluorescent peptide probe FAM-GFO. Fluorescence
micrographs of liver fibrosis (a, e, i), liver cancer (b, f, j), rectal
cancer (c, g, k), and esophageal cancer (d, h, l); tissue sections
stained with FAM-GFO (in green) and DAPI (in blue). Scale bar = 50
μm.
Conclusions
The discovery of novel peptide probes to specifically detect denatured
collagen has received increasing attention since denatured collagen
is intimately correlated with various critical diseases such as cancer.[40−42] Recent progress of the collagen-targeting peptide probes is predominantly
dependent on the inclusion of the repetitive (Gly-Pro-Hyp) sequences, whose high triple helical stability
may hinder their clinical applications.[43,44] Previous studies
have indicated that the presence of nonimino acids in the X and Y
positions of the (Gly-X-Y) sequences
would weaken the triple helical stability, while the extent of the
destabilization depended on the identity of the nonimino acids.[45,46]Herein, we have constructed a series of peptide probes by
introducing nonimino acids at the X position of the (GPO)3GXO(GPO)4 sequence, while the X-site residue is varied
as Tyr, Phe, Asp, and Ala, respectively. We have systematically investigated
the effect of the identity of the X residue on the collagen-targeting
capability by utilizing protein-binding assays and tissue-staining
experiments. Compared with Pro at the X position, the inclusion of
aromatic residues Tyr and Phe did not significantly affect the binding
affinity and tissue-staining efficacy of the peptide probes, while
the presence of a charged residue Asp and a hydrophobic residue Ala
largely reduced their binding affinity and tissue-staining capability.
In addition, the replacement of Pro by Tyr or Ala at two X positions
significantly interfered in the binding and staining of collagen by
the peptide probes, suggesting that the inclusion of multiple nonimino
acids may impair their collagen-targeting efficiency.The two
peptide probes FAM-GYO and FAM-GFO containing aromatic residues Tyr
and Phe at a single X position have further been shown to specifically
target denatured collagen in various types of mouse connective tissues
and they have been successfully applied for efficiently staining different
human pathological tissues. We have revealed for the first time that
aromatic residues could be incorporated in the construction of robust
collagen-targeting peptides. Previous studies have shown that aromatic
interactions could promote the self-association of triple helical
peptides and fibrillogenesis of type I collagen.[38,39] Our results suggested that aromatic interactions may facilitate
the peptide probes to bind with denatured collagen. Among all types
of imino acids at the X position, aromatic residues have been shown
to be the most destabilizing residues for a triple-helix conformation.
The incorporation of nonimino acids, particularly aromatic residues
at the X and Y positions, may provide a convenient strategy to create
novel potent collagen-targeting peptide probes, which have promising
diagnostic applications in collagen-involved diseases.
Experimental Section
Materials
Rink
amide resin (200–400 mesh, loading = 0.345 mmol/g), Fmoc-Gly-OH,
Fmoc-Pro-OH, Fmoc-Hyp(tBu)-OH, Fmoc-Asp(Otbu)-OH, Fmoc-Tyr(tBu)-OH,
Fmoc-Ala-OH, Fmoc-Phe-OH, O-Benzotriazole-N,N,N′,N′-tetramethyl-uronium-hexafluorophosphate (HBTU),
and N-hydroxybenzotriazole (HOBt, anhydrous) were
purchased from GL Biochemical Company (Shanghai, China). N,N-Diisopropylethylamine (DIEA) was obtained from
Hanhong Chemical Technology Co. Ltd (Shanghai, China). 5(6)-Carboxylfluorescein
(FAM) and piperazine (anhydrous) were provided by Aladdin Industrial
Corporation (Shanghai, China). Trifluoroacetic acid (TFA) and triisopropylsilane
(Tis) were purchased from Tokyo Chemical Industry Co. Ltd (Tokyo,
Japan). Bovineserum albumin (BSA), goat serum, and 4′,6-diamidino-2-phenylindole
(DAPI) were obtained from Solarbio Science & Technology Co. Ltd
(Beijing, China). Hemoglobin, trypsin, and pepsin were obtained from
Yuanye Biological Technology Co. Ltd (Shanghai, China). Gelatin was
obtained from Biotop Science & Technology Co. Ltd (Beijing, China).
All of the commercial reagents were of analytical grade and were used
without further purification.
Peptide
Synthesis
Peptides were synthesized in-house by a standard
Fmoc solid-phase synthesis (SPPS) method. Fmoc-amino acids (Fmoc-Gly-OH,
Fmoc-Pro-OH, Fmoc-Hyp(tBu)-OH, Fmoc-Asp(Otbu)-OH, Fmoc-Tyr(tBu)-OH,
Fmoc-Phe-OH, and Fmoc-Ala-OH) (5 equiv), HBTU (5 equiv), and DIEA
(8 equiv) in N,N-dimethylformamide
(DMF) were applied during each step of amino acid coupling. Resin
was washed by DMF (3 × 10 mL) and dichloromethane (DCM, 2 ×
10 mL). Fmoc protection groups were then eliminated by 5% piperazine
in DMF. The status of coupling and deprotection reactions was monitored
by the chloranil test. After the completion of coupling all amino
acids, FAM was conjugated to the N-terminal of the peptide using FAM
(5 equiv), HBTU (5 equiv), and DIEA (8 equiv) in DMF. At the end of
peptide synthesis, the resins were treated with TFA/TIS/H2O (95:2.5:2.5) for 3 h to remove the tBu and Otbu groups and release
the peptide from the resin. The peptides were harvested by precipitation
with cold Et2O. Crude peptides were collected after resuspension
in cold Et2O, sonication, and centrifugation. All of the
peptides were purified using reverse-phase high-performance liquid
chromatography (HPLC) on a C18 column, and the purity of the peptides
was confirmed by matrix assisted laser desorption ionization-time
of flight (MALDI-TOF) mass spectrometry (Bruker, Germany). The peptide
was lyophilized and stored at −20 °C for future use.
Protein-Binding Assay
Gelatin (1 mg/mL)
was prepared in 10 mM PBS (pH 7.4) at 70 °C. Seventy microliters
of gelatin was added into each well of a 96-well plate and air-dried.
After coating, the gelatin film was washed with 400 μL of 10
mM PBS (pH 7.4) for 3 min three times. Hundred microliters of the
solution of BSA in 10 mM PBS (pH 7.4) (1% v/v) was added and incubated
at room temperature for 1 h to block nonspecific binding. The plate
was washed with 400 μL of 10 mM PBS (pH 7.4) for 3 min three
times. Seventy microliters of the solution of 20 μM fluorescent
peptide probes (FAM-GPO, FAM-GYO, FAM-GFO, FAM-GDO, FAM-GAO, FAM-2GYO,
FAM-2GAO, or FAM-control) in 10 mM PBS (pH 7.4) was added to each
well and incubated at 4 °C for 4 h to ensure their binding to
the gelatin films. All fluorescent peptide probes were heated at 80
°C for 15 min and quenched in ice water for 30 s prior to the
usage. The wells were washed with 400 μL of 10 mM PBS (pH 7.4)
for 5 min three times. Fluorescence (ex: 495 nm, em: 541 nm) was measured
on an Infinite M200 (TECAN Corporation, Switzerland). Each measurement
was repeated three times.The binding affinity of the peptide
probes FAM-GPO, FAM-GYO, and FAM-GFO toward denatured collagen, hemoglobin,
pepsin, and trypsin was similarly determined. Type I collagen was
dissolved in a 0.5 M acetic acid solution and denatured by heating
at 70 °C for 15 min. Solutions of collagen, hemoglobin, pepsin,
and trypsin with a concentration of 1 mg/mL were prepared in 10 mM
PBS (pH 7.4). The protein solutions were added into the wells of a
96-well plate and air-dried. After coating, the protein film was washed
with 400 μL of 10 mM PBS (pH 7.4) for 3 min three times. FAM-GPO,
FAM-GYO, and FAM-GFO were heated at 80 °C for 15 min and quenched
in ice water for 30 s. The three peptide probes were then added to
each well, respectively, and incubated at 4 °C for 4 h. The wells
were washed with 400 μL of 10 mM PBS (pH 7.4) for 5 min three
times. Fluorescence (ex: 495 nm, em: 541 nm) was measured on an Infinite
M200 (TECAN Corporation, Switzerland). Each measurement was repeated
three times.
Tissue Staining and Imaging
The ear, intestine, heart, cartilage, and eye tissues were obtained
from 7–8 week old KM mice (18–22 g). All tissues were
fixed with 4% paraformaldehyde in 10 mM PBS (pH 7.4) for 1 h and embedded
in paraffin. The tissues were sectioned to 4 μm thickness on
poly-lysine treated glass slides. Paraffin was washed away using xylene,
100% ethanol, 95% ethanol, 80% ethanol, and deionized water for two
cycles of 5 min for each solvent in a consecutive order. The ear,
intestine, heart, cartilage, and eye tissues were treated with ultrapure
water at 85 °C for 10 min to denature collagen. Goat serum solution
(0.5 mL) in PBS (5% v/v) was added onto each tissue slide and incubated
at room temperature for 30 min to block nonspecific binding. The blocking
solution was removed with a paper towel.The solutions of peptide
probes (FAM-GPO, FAM-GYO, FAM-GFO, FAM-GDO, FAM-GAO, FAM-2GYO, FAM-2GAO,
and FAM-control) were heated at 80 °C for 15 min and quenched
in ice water for 30 s prior to the usage. Normal and thermally impaired
tissue sections were treated with 100 μL of solutions of preheated
peptide probes (15 μM) in 10 mM PBS (pH 7.4), and incubated
at 4 °C for 4 h. The slides were covered with parafilm to prevent
drying during the incubation. After the staining using the peptide
probes, the parafilm was removed and excess solution was wiped away
by a paper towel. Two hundred microliters of DAPI (5 μg/mL)
solution in 10 mM PBS was applied to each tissue slide and incubated
at room temperature for 1 min. After DAPI staining, the slides were
immersed in a staining tank in 10 mM PBS buffer for 5 min 5 times
to wash off the unbound DAPI. Denatured collagen (FAM channels) and
nuclei (DAPI channels) in the tissue slides were imaged on a Leica
DM4000B metallurgical upright microscope (Leica Microsystems Inc.,
Wetzlar, Germany).For the inhibition experiments, a solution
of an inhibitor peptide G(POG)10 (15 μM) was prepared
and heated at 85 °C for 30 min to make the peptide in the single-stranded
conformation. Two hundred microliters of the G(POG)10 solution
was immediately applied onto the impaired intestine tissues prior
to staining the tissue slides using fluorescent peptide probes. The
tissue slides were incubated at 4 °C for 4 h to ensure complete
binding of the inhibitor with denatured collagen. PBS buffer (10 mM,
pH 7.4) was applied five times to rinse the tissue slides and eliminate
the unbound inhibitors.
Pathological Human Tissue
Staining and Imaging
Pathological humantissues of liver
fibrosis, liver cancer, rectal cancer, and esophageal cancer were
provided by The First Hospital of Lanzhou University. The tissues
were fixed with 4% paraformaldehyde in a 10 mM PBS solution (pH 7.4)
for 1 h and embedded in paraffin. The tissues were sectioned to 4
μm thickness on poly-lysine-treated glass slides. Paraffin was
washed away using xylene, 100% ethanol, 95% ethanol, 50% ethanol,
and deionized water for two cycles of 5 min for each solvent in a
consecutive order. Goat serum solution (0.5 mL) in PBS (5% v/v) was
added onto each tissue slide and incubated at room temperature for
30 min to block nonspecific binding. The blocking solution was removed
with a paper towel.The solutions of peptide probes FAM-GYO
and FAM-GFO (15 μM) were heated at 80 °C for 15 min and
quenched in ice water for 30 s prior to the usage. The tissue sections
were treated with 100 μL of solutions of preheated peptide probes
in 10 mM PBS (pH 7.4), and incubated at 4 °C for 4 h. The slides
were covered with parafilm to prevent drying during the incubation.
After the staining using the peptide probes, the parafilm was removed
and excess solution was wiped away by a paper towel. Two hundred microliters
of a DAPI (5 μg/mL) solution in 10 mM PBS was applied to each
tissue slide and incubated at room temperature for 1 min. After DAPI
staining, the slides were immersed in a staining tank in 10 mM PBS
buffer for 5 min 5 times to wash off the unbound DAPI. Denatured collagen
(FAM channels) and nuclei (DAPI channels) in the tissue slides were
imaged on a Leica DM4000B metallurgical upright microscope (Leica
Microsystems Inc., Wetzlar, Germany).
Authors: V Biasin; M Wygrecka; L M Marsh; C Becker-Pauly; L Brcic; B Ghanim; W Klepetko; A Olschewski; G Kwapiszewska Journal: Sci Rep Date: 2017-01-06 Impact factor: 4.379